These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4378121)

  • 1. Vitiligo and sympathectomy. The effect of sympathectomy and alpha- melanocyte stimulating hormone.
    Lerner AB; Snell RS; Chanco-Turner ML; McGuire JS
    Arch Dermatol; 1966 Sep; 94(3):269-78. PubMed ID: 4378121
    [No Abstract]   [Full Text] [Related]  

  • 2. Topical application of a melanotropin analogue to vulgar vitiligo dermo-epidermal minigrafts.
    Schwartzmann-Solon AM; Visconti MA; Castrucci AM
    Braz J Med Biol Res; 1998 Dec; 31(12):1557-64. PubMed ID: 9951552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo.
    Grimes PE; Hamzavi I; Lebwohl M; Ortonne JP; Lim HW
    JAMA Dermatol; 2013 Jan; 149(1):68-73. PubMed ID: 23407924
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Melanotropic peptides for therapeutic and cosmetic tanning of the skin.
    Hadley ME; Sharma SD; Hruby VJ; Levine N; Dorr RT
    Ann N Y Acad Sci; 1993 May; 680():424-39. PubMed ID: 8390162
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunohistochemical study of ACTH and alpha-MSH in vitiligo patients successfully treated with a sex steroid-thyroid hormone mixture.
    Ichimiya M
    J Dermatol; 1999 Aug; 26(8):502-6. PubMed ID: 10487004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alpha-melanocyte stimulating hormone analogues: the perils and the promise.
    Mazza JM; Zippin JH
    J Drugs Dermatol; 2009 Aug; 8(8):772-6. PubMed ID: 19663117
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic photoprotection in solar urticaria with α-melanocyte-stimulating hormone analogue [Nle4-D-Phe7]-α-MSH.
    Haylett AK; Nie Z; Brownrigg M; Taylor R; Rhodes LE
    Br J Dermatol; 2011 Feb; 164(2):407-14. PubMed ID: 20969564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tofacitinib combined with melanocyte protector α-MSH to treat vitiligo through dextran based hydrogel microneedles.
    Liang J; Yu Y; Li C; Li Q; Chen P; Li W; Liu W; Li Z; Liu Y; Zhang S; Zhang X
    Carbohydr Polym; 2023 Apr; 305():120549. PubMed ID: 36737198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repigmentation of skin and hairs in stable vitiligo by transplantation of autologous melanocytes in fibrin suspension.
    Hartmann A; Broecker EB; Hamm H
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):624-6. PubMed ID: 18410624
    [No Abstract]   [Full Text] [Related]  

  • 10. Histamine released from epidermal keratinocytes plays a role in α-melanocyte-stimulating hormone-induced itching in mice.
    Shimizu K; Andoh T; Yoshihisa Y; Shimizu T
    Am J Pathol; 2015 Nov; 185(11):3003-10. PubMed ID: 26358220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Local pigment stimulation by alpha-melanocyte stimulating hormone in the human: intracutaneous injections without and with ultraviolet irradiation].
    Remy W; Rakoski J; von Mayenburg J
    Z Hautkr; 1989 Jun; 64(6):459-60. PubMed ID: 2548353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repigmentation of vitiligo during efalizumab.
    Wakkee M; Assen YJ; Thio HB; Neumann HA
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S57-8. PubMed ID: 18625392
    [No Abstract]   [Full Text] [Related]  

  • 13. Therapeutic update on vitiligo.
    Sarnoff DS
    J Drugs Dermatol; 2015 Feb; 14(2):109-11. PubMed ID: 25689803
    [No Abstract]   [Full Text] [Related]  

  • 14. Non-psoralen treatment of vitiligo. Part II. Less commonly used and experimental therapies.
    Goldstein E; Haberman HF; Menon IA; Pawlowski D
    Int J Dermatol; 1992 May; 31(5):314-9. PubMed ID: 1587657
    [No Abstract]   [Full Text] [Related]  

  • 15. Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir.
    Dogra S; Kumar B
    Dermatol Online J; 2005 Dec; 11(3):30. PubMed ID: 16409926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The minigrafting test for vitiligo: detection of stable lesions for melanocyte transplantation.
    Falabella R; Arrunategui A; Barona MI; Alzate A
    J Am Acad Dermatol; 1995 Feb; 32(2 Pt 1):228-32. PubMed ID: 7829707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatitis produced by applications of monobenzone in patients with active vitiligo.
    Nordlund JJ; Forget B; Kirkwood J; Lerner AB
    Arch Dermatol; 1985 Sep; 121(9):1141-4. PubMed ID: 2931053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative stress via hydrogen peroxide affects proopiomelanocortin peptides directly in the epidermis of patients with vitiligo.
    Spencer JD; Gibbons NC; Rokos H; Peters EM; Wood JM; Schallreuter KU
    J Invest Dermatol; 2007 Feb; 127(2):411-20. PubMed ID: 16946714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reagents inducing epidermal proliferation also induce pigmentation: induction of keratinocyte proliferation as a novel strategy for the treatment of vitiligo.
    Wu CS; Komine M; Fujimoto S; Ohmatsu H; Kikuchi K; Tada Y; Yu HS; Ohtsuki M; Tamaki K
    J Dermatol Sci; 2013 Oct; 72(1):66-8. PubMed ID: 23876305
    [No Abstract]   [Full Text] [Related]  

  • 20. Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation.
    Mulekar SV
    Arch Dermatol; 2004 Oct; 140(10):1211-5. PubMed ID: 15492183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.